Thus, patients with acute IM showed elevated MOG-specific IgG and vimentin-specific IgM responses as compared with children with acute upper respiratory tract infections not associated with EBV infection (cohort 1) and with non-inflammatory disease conditions (cohort 2). This evidence concerns the gene MOG and Recurrent upper respiratory tract infections.